The prevalence and predictors of airway hyperresponsiveness in sarcoidosis

Respirology

Volumn 17, Issue 4, 2012, Pages 653-659

  Young, Lisa M ^a   Good, Nichola ^a   Milne, David ^a   Zeng, Irene ^a   Kolbe, John ^a,b   Wilsher, Margaret L ^a  

^a AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

asthma; bronchoprovocation; histamine; hypertonic saline; sarcoidosis

Indexed keywords

HISTAMINE; SODIUM CHLORIDE;

ADULT; AIRWAY HYPERRESPONSIVENESS; AIRWAY REMODELING; ARTICLE; BRONCHUS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TREATMENT RESPONSE;

ADULT; AIRWAY REMODELING; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY;

EID: 84859894565     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02137.x     Document Type: Article

References (35)

1. Harrison BD, Shaylor JM, Stokes TC, et al,. Airflow limitation in sarcoidosis-a study of pulmonary function in 107 patients with newly diagnosed disease. Respir. Med. 1991; 85: 59-64.
2. Cieslicki J, Zych D, Zielinski J,. Airways obstruction in patients with sarcoidosis. Sarcoidosis 1991; 8: 42-4.
3. Lewis MI, Horak DA,. Airflow obstruction in sarcoidosis. Chest 1987; 92: 582-4.
4. Young RC, Jr, Sahetya GK, Hassan SN, et al,. Chronic airways obstruction in pulmonary sarcoidosis: its poor response to bronchodilators. J. Natl Med. Assoc. 1980; 72: 965-72. (Pubitemid 11255721)
5. Hansell DM, Milne DG, Wilsher ML, et al,. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 1998; 209: 697-704. (Pubitemid 28564901)
6. Holgate ST, Beasley R, Twentyman OP,. The pathogenesis and significance of bronchial hyper-responsiveness in airways disease. Clin. Sci. (Lond.) 1987; 73: 561-72. (Pubitemid 18013285)
7. Bechtel JJ, Starr T III, Dantzker DR, et al,. Airway hyperreactivity in patients with sarcoidosis. Am. Rev. Respir. Dis. 1981; 124: 759-61. (Pubitemid 12200154)
8. Marcias S, Ledda MA, Perra R, et al,. Aspecific bronchial hyperreactivity in pulmonary sarcoidosis. Sarcoidosis 1994; 11: 118-22. (Pubitemid 24311241)
9. Olafsson M, Simonsson BG, Hansson SB,. Bronchial reactivity in patients with recent pulmonary sarcoidosis. Thorax 1985; 40: 51-3. (Pubitemid 15110832)
10. Presas FP, Colomer PR, Rodrigues S,. Bronchial hyperractivity in fresh stage I sarcoidosis. Ann. N. Y. Acad. Sci. 1986; 465: 523-9. (Pubitemid 16006592)
11. Shorr AF, Torrington KG, Hnatiuk OW,. Endobronchial involvement and airway hyperreactivity in patients with sarcoidosis. Chest 2001; 120: 881-6. (Pubitemid 32885464)
12. Ohrn MB, Skold CM, van Hage-Hamsten M, et al,. Sarcoidosis patients have bronchial hyperreactivity and signs of mast cell activation in their bronchoalveolar lavage. Respiration 1995; 62: 136-42.
13. Salome CM, Roberts AM, Brown NJ, et al,. Exhaled nitric oxide measurements in a population sample of young adults. Am. J. Respir. Crit. Care Med. 1999; 159: 911-16. (Pubitemid 29137795)
14. van den Berge M, Meijer RJ, Kerstjens HA, et al,. PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am. J. Respir. Crit. Care Med. 2001; 163: 1546-50. (Pubitemid 32578753)
15. Wilsher ML, Fergusson W, Milne D, et al,. Exhaled nitric oxide in sarcoidosis. Thorax 2005; 60: 967-70. (Pubitemid 41598214)
16. Wilsher M, Hopkins R, Zeng I, et al,. Prevalence of asthma and atopy in sarcoidosis. Respirology 2012; 17: 285-90.
17. Ward K, O'Connor C, Odlum C, et al,. Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 1989; 44: 6-12. (Pubitemid 19035379)
18. Roth C, Huchon GJ, Arnoux A, et al,. Bronchoalveolar cells in advanced pulmonary sarcoidosis. Am. Rev. Respir. Dis. 1981; 124: 9-12. (Pubitemid 11079333)
19. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am. Rev. Respir. Dis. 1987; 136: 1285-98.
20. Standardized lung function testing. Report of Working Party. European Community for Coal and Steel Recommendations. Bull. Eur. Physiopathol. Respir. 1983; 19 (Suppl. 5): 1-93.
21. Smith CM, Anderson SD, Black JL,. Methacholine responsiveness increases after ultrasonically nebulized water but not after ultrasonically nebulized hypertonic saline in patients with asthma. J. Allergy Clin. Immunol. 1987; 79: 85-92. (Pubitemid 17008926)
22. Smith CM, Anderson SD,. Inhalation provocation tests using nonisotonic aerosols. J. Allergy Clin. Immunol. 1989; 84 (5 Pt 1): 781-90. (Pubitemid 20008512)
23. Yan K, Salome C, Woolcock AJ,. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38: 760-5. (Pubitemid 13019506)
24. Cockcroft DW, Berscheid BA, Murdock KY,. Measurement of responsiveness to inhaled histamine using FEV1: comparison of PC20 and threshold. Thorax 1983; 38: 523-6. (Pubitemid 13030336)
25. Holt S, Beasley R,. The Burden of Asthma in New Zealand. Adis International, Auckland, 2001; ISBN 0-86471-094-1.
26. Crapo RO, Casaburi R, Coates AL, et al,. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am. J. Respir. Crit. Care Med. 2000; 161: 309-29. (Pubitemid 30055941)
27. Shelhamer JH, Levine SJ, Wu T, et al,. NIH conference. Airway inflammation. Ann. Intern. Med. 1995; 123: 288-304.
28. Pare PD, Bai TR,. The consequences of chronic allergic inflammation. Thorax 1995; 50: 328-32.
29. Black JL, Roth M, Lee J, et al,. Mechanisms of airway remodeling. Airway smooth muscle. Am. J. Respir. Crit. Care Med. 2001; 164 (10 Pt 2): S63-S66.
30. James AL, Pare PD, Hogg JC,. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 1989; 139: 242-6. (Pubitemid 19030451)
31. Fredberg JJ,. Airway smooth muscle in asthma: flirting with disaster. Eur. Respir. J. 1998; 12: 1252-6. (Pubitemid 29011411)
32. Hansell DM, Rubens MB, Padley SP, et al,. Obliterative bronchiolitis: individual CT signs of small airways disease and functional correlation. Radiology 1997; 203: 721-6. (Pubitemid 27227420)
33. Alberts C, van der Mark TW, Jansen HM,. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis. Eur. Respir. J. 1995; 8: 682-8.
34. Milman N, Graudal N, Grode G, et al,. No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study. J. Intern. Med. 1994; 236: 285-90. (Pubitemid 24283067)
35. Bradley B, Branley HM, Egan JJ, et al,. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 (Suppl. 5): v1-58.